Literature DB >> 31933047

Cumulative risk regression in case-cohort studies using pseudo-observations.

Erik T Parner1, Per K Andersen2, Morten Overgaard3.   

Abstract

Case-cohort studies are useful when information on certain risk factors is difficult or costly to ascertain. Particularly, a case-cohort study may be well suited in situations where several case series are of interest, e.g. in studies with competing risks, because the same sub-cohort may serve as a comparison group for all case series. Previous analyses of this kind of sampled cohort data most often involved estimation of rate ratios based on a Cox regression model. However, with competing risks this method will not provide parameters that directly describe the association between covariates and cumulative risks. In this paper, we study regression analysis of cause-specific cumulative risks in case-cohort studies using pseudo-observations. We focus mainly on the situation with competing risks. However, as a by-product, we also develop a method by which absolute mortality risks may be analyzed directly from case-cohort survival data. We adjust for the case-cohort sampling by inverse sampling probabilities applied to a generalized estimation equation. The large-sample properties of the proposed estimator are developed and small-sample properties are evaluated in a simulation study. We apply the methodology to study the effect of a specific diet component and a specific gene on the absolute risk of atrial fibrillation.

Entities:  

Keywords:  Case–cohort study; Competing risks; Cumulative incidence; Cumulative risk; Pseudo-observations

Year:  2020        PMID: 31933047     DOI: 10.1007/s10985-020-09492-3

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  1 in total

1.  Competing risks regression models with covariates-adjusted censoring weight under the generalized case-cohort design.

Authors:  Yayun Xu; Soyoung Kim; Mei-Jie Zhang; David Couper; Kwang Woo Ahn
Journal:  Lifetime Data Anal       Date:  2022-01-15       Impact factor: 1.588

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.